RESUMEN
Yersiniosis, caused by Yersinia ruckeri, has become the most common disease in farmed rainbow trout Oncorhynchus mykiss in Peru, affecting Puno and Junín Regions, important aquaculture areas in the country. Florfenicol (FLO) and oxytetracycline (OXY) are the antimicrobials most frequently used to mitigate losses attributed to this pathogen. This study presents an analysis of the susceptibility patterns of 60 Y. ruckeri isolates (30 isolates each from Puno and Junín), including the type strain CECT 4319T and the strains CECT 955 and CECT 956, against FLO and OXY. Minimum inhibitory concentrations (MICs) were determined following the guideline for standard broth dilution method published by the Clinical and Laboratory Standards Institute. MIC results ranged from 4.0 to 8.0 µg ml-1 for FLO and 0.5 to 4.0 µg ml-1 for OXY. Normalized resistance interpretation (NRI) analysis identified epidemiological cut-off values of ≤16.0 µg ml-1 for FLO and ≤4.0 µg ml-1 for OXY. All Peruvian isolates, including the collection strains, were categorized as wild-type for both antimicrobials. Even though the number of Y. ruckeri isolates with MIC values of 8 µg ml-1 for FLO is more than double in Puno than in Junín (15 vs. 7 isolates), the NRI analysis showed the same epidemiological cutoff of 16 µg ml-1; while for OXY, it was 4.0 µg ml-1 for Puno and 2.0 µg ml-1 for Junín. This study establishes the basis for monitoring susceptibility to FLO and OXY in new Y. ruckeri isolates in Peruvian rainbow trout farming.
Asunto(s)
Antibacterianos , Enfermedades de los Peces , Pruebas de Sensibilidad Microbiana , Oxitetraciclina , Tianfenicol , Yersinia ruckeri , Antibacterianos/farmacología , Tianfenicol/análogos & derivados , Tianfenicol/farmacología , Yersinia ruckeri/efectos de los fármacos , Perú/epidemiología , Oxitetraciclina/farmacología , Animales , Enfermedades de los Peces/microbiología , Farmacorresistencia Bacteriana , Yersiniosis/veterinaria , Yersiniosis/microbiología , Oncorhynchus mykissRESUMEN
In order to establish the meaning of data generated in antimicrobial agent susceptibility tests, it is necessary to develop internationally harmonised interpretive criteria. Currently, such criteria have not been developed for data generated in studies of the susceptibility of the fish pathogen Yersinia ruckeri. This work generated the data that would be required to set epidemiological cut-off values for the susceptibility data of this species that had been generated using a standardised disc diffusion method that specified the use of Mueller Hinton agar and incubation at 22°C for 24-28 h. Using this method, sets of inhibition zones data for 4 antimicrobial agents were generated by 3 independent laboratories. The data from these laboratories were aggregated and analysed using the statistically based normalised resistance interpretation. For ampicillin, florfenicol, oxytetracycline and trimethoprim-sulfamethoxazole the cut-off values calculated by this analysis were ≥16, ≥23, ≥24 and ≥30 mm, respectively. Evidence is presented demonstrating that the data for these 4 agents was of sufficient quantity and quality that they could be used by the relevant authorities to set internationally harmonised, consensus epidemiological cut-off values for Y. ruckeri.
Asunto(s)
Antibacterianos , Enfermedades de los Peces , Yersinia ruckeri , Antibacterianos/farmacología , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/epidemiología , Yersinia ruckeri/efectos de los fármacos , Animales , Pruebas de Sensibilidad Microbiana , Yersiniosis/veterinaria , Yersiniosis/microbiología , Yersiniosis/epidemiología , Farmacorresistencia Bacteriana , PecesRESUMEN
Standard disc diffusion and MIC test procedure were used to investigate the susceptibility of two hundred and fifty-one isolates collected from infected fish in France to florfenicol, oxolinic acid and tetracycline. The tests were performed at 22 ± 2â and for the 177 Yersinia ruckeri they were read after 24-28 hr incubation and for the 74 Aeromonas salmonicida isolates they were read after 44-48 hr. Applying epidemiological cut-off values to the susceptibility data generated in these tests, the isolates were categorized as wild-type or non-wild-type. The agent-specific categories into each isolate were placed on the basis of the data generated by the two methods were in agreement in 98% of the determinations made. It is argued that, with respect to categorising isolates, disc diffusion and MIC methods can be considered as equally valid at this temperature and after both periods of incubation.
Asunto(s)
Aeromonas salmonicida/efectos de los fármacos , Antibacterianos/farmacología , Yersinia ruckeri/efectos de los fármacos , Farmacorresistencia Bacteriana , Pruebas de Sensibilidad Microbiana , Ácido Oxolínico/farmacología , Tetraciclina/farmacología , Tianfenicol/análogos & derivados , Tianfenicol/farmacologíaRESUMEN
In this 21-day study, we examined the effects of the aqueous methanolic extract of thin-skinned plum (Prunus domestica) on growth, immune response and resistance to a pathogenic bacterium, Yersinia ruckeri in rainbow trout (Oncorhynchus mykiss). Fish were fed with diets containing thin-skinned plum extract doses as 0 (Control) 0.1 (PD01), 0.5 (PD05) and 1% (PD1) ad libitum twice in a day. At the end of the study, growth was affected positively but not significantly. Feed conversion ratio (FCR) was decreased in the PD01 group (P < 0.05). There were elevated respiratory burst and potential bacterial killing activities on the 7th day in the PD1 fish group. No differences were observed in lysozyme activity (P > 0.05). An increased myeloperoxidase activity was recorded on the 14th day of study. Expression of interleukin and COX-2 genes was elevated on the 7th day of study in the kidney and intestine of treated fish. Histological results indicated no marked changes in organs (gill, kidney, liver and spleen) of PD treated fish groups. Challenge results of fish in all plum extract-treated groups showed an increased survival rate against Y. ruckeri (P < 0.05). This study indicated that the thin-skinned plum aqueous methanolic extract could improve innate immunity, survival against Y. ruckeri and decrease the FCR level.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Resistencia a la Enfermedad , Enfermedades de los Peces/prevención & control , Oncorhynchus mykiss/inmunología , Extractos Vegetales/farmacología , Yersinia ruckeri/efectos de los fármacos , Animales , Enfermedades de los Peces/microbiología , Oncorhynchus mykiss/crecimiento & desarrollo , Prunus domestica/química , Yersiniosis/microbiología , Yersiniosis/prevención & control , Yersiniosis/veterinariaRESUMEN
This study investigated the effects of Greek juniper extract on immune responses of rainbow trout. In this experiment, 4 doses [0 (Control), 1 (J1), 4 (J4) and 8 (J8) mg/kg] of the extract were administered orally using an oral gavage twice a day for 14 days. Immune responses were measured on 7th and 14th days. On 14th day, Yersinia ruckeri was injected intraperitoneally to all fish of all groups. On 14th day, ORP in fish of J1 group increased significantly. Lysozyme activity (LA) was increased in J8 group on 7th day (p < .05). On 14th day, a significant decrease was determined in J1 and J4 treatments in LA. Myeloperoxidase activity was significantly decreased in all groups irrespective of sampling times (p < .05). Interleukin (IL)-1ß was significantly elevated in fish of J8 group on 7th day. IL-8 increased in fish of J8 and J4 groups on 7th day of the study. IL-12 gene expression was significantly up-regulated in J8 fish group on 7th day, and in J4 fish group on 14th day. Survival rate was higher in J8 treatment compared to the control and other treatments (p < .05). The results suggest that Juniperus excelsa provides protection against Y. ruckeri in rainbow trout.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Resistencia a la Enfermedad/inmunología , Enfermedades de los Peces/tratamiento farmacológico , Inmunidad Innata , Juniperus/química , Oncorhynchus mykiss , Yersiniosis/veterinaria , Adyuvantes Inmunológicos/química , Animales , Resistencia a la Enfermedad/efectos de los fármacos , Enfermedades de los Peces/inmunología , Inmunidad Innata/efectos de los fármacos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Yersiniosis/tratamiento farmacológico , Yersiniosis/inmunología , Yersinia ruckeri/efectos de los fármacos , Yersinia ruckeri/fisiologíaRESUMEN
In the current study, we investigated the effect of a probiotic bacterium (Lactobacillus rhamnosus ATCC 7469) microencapsulated with alginate and hi-maize starch and coated with chitosan on improving growth factors, body composition, blood chemistry, and the immune response of rainbow trout (initial weight: 18.41 ± 0.32 g). Four experimental diets were formulated to feed fish for 60 days. They were control diet without any additive (C), diet added with beads without probiotic (E), a probiotic sprayed to the diet (L.r), and encapsulated probiotic supplemented diet (E-L.r). The results indicated that feeding with E-Lr significantly improved weight gain (84.98 g) and feed conversion ratio (0.95) compared to the other groups (P < 0.05). Also, fish fed E-Lr diet had a significantly higher value of whole-body protein (17.51%), total protein in the blood (4.98 g/dL), lysozyme (30.66 U/mL), alternative complement pathway hemolytic activity (134 U/mL), superoxide dismutase (203 U/mg protein), and catalase (528.33 U/mg protein) (P < 0.05) as compared to those fed the control diet. Similarly, a higher relative expression of immune-related genes such as interleukin-1 (Il-1) and tumor necrosis factor-alpha (TNF-1α) were reported in those fed E-L.r and L.r diets respectively. Interestingly, the fish fed dietary E-L.r had a significantly lower value of lipid in the whole body (4.82%) and cholesterol in the blood (160.67%) in comparison with those fed the control diet (P < 0.05). At the end of the experiment, all groups were challenged by Yersinia ruckeri where the survival rate of rainbow trout fed dietary E-L.r (70.36%) was statistically higher than that of the others (P < 0.05). Overall, the results suggested that encapsulated probiotic Lact. rhamnosus ATCC 7469 acted better than unencapsulated probiotic and has a potential to improve growth performance, flesh quality, and the immune response of rainbow trout.
Asunto(s)
Enfermedades de los Peces/terapia , Proteínas de Peces/genética , Regulación de la Expresión Génica/efectos de los fármacos , Lacticaseibacillus rhamnosus/fisiología , Oncorhynchus mykiss/inmunología , Probióticos/farmacología , Yersiniosis/terapia , Alginatos/química , Alimentación Animal/análisis , Animales , Composición Corporal/efectos de los fármacos , Catalasa/genética , Catalasa/inmunología , Encapsulación Celular/métodos , Células Inmovilizadas , Quitosano/química , Colesterol/sangre , Vía Alternativa del Complemento/efectos de los fármacos , Dieta , Resistencia a la Enfermedad/efectos de los fármacos , Resistencia a la Enfermedad/genética , Resistencia a la Enfermedad/inmunología , Enfermedades de los Peces/inmunología , Enfermedades de los Peces/microbiología , Proteínas de Peces/inmunología , Regulación de la Expresión Génica/inmunología , Interleucina-1/genética , Interleucina-1/inmunología , Muramidasa/genética , Muramidasa/inmunología , Oncorhynchus mykiss/crecimiento & desarrollo , Oncorhynchus mykiss/microbiología , Superóxido Dismutasa/genética , Superóxido Dismutasa/inmunología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Aumento de Peso/efectos de los fármacos , Yersiniosis/inmunología , Yersiniosis/microbiología , Yersinia ruckeri/efectos de los fármacos , Yersinia ruckeri/crecimiento & desarrollo , Yersinia ruckeri/patogenicidadAsunto(s)
Antibacterianos/farmacología , Enfermedades de los Peces/microbiología , Pruebas de Sensibilidad Microbiana/veterinaria , Oncorhynchus mykiss , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Animales , Perú , Fenotipo , Yersiniosis/microbiología , Yersinia ruckeri/fisiologíaRESUMEN
Bacterial antibiotic resistance is one of the main healthcare problems currently. Apart from reducing antibiotic efficacy, it has awakened the interest of scientists due to its association with bacterial fitness and virulence. Interestingly, antibiotic resistance can be a source of both increased fitness and decreased fitness, even though the molecular basis of these relationships remains unknown. The aim of this work is to define the effects of sub-MIC concentrations of cefotaxime, an antibiotic extensively used in clinical practice, on the physiology and virulence of Yersinia ruckeri and to determine the importance of these sub-MIC concentrations for the selection of antibiotic-resistant mutants in the aquatic environment. Results indicated that exposure to sub-MIC concentrations of cefotaxime selected Y. ruckeri populations with irreversible alterations in the physiology, such as slow growth, aggregation in liquid cultures and modification of the colony morphology. These bacteria also displayed changes in the OMPs and LPS profiles and a full attenuation of virulence. An overexpression of the envelope stress regulator RpoE was also detected after exposure to the antibiotic. In conclusion, exposure to cefotaxime selected, at high frequency, Y. ruckeri strains that survive the antibiotic stress at the expense of a fitness cost and the loss of virulence.
Asunto(s)
Antibacterianos/farmacología , Cefotaxima/farmacología , Farmacorresistencia Bacteriana/genética , Virulencia , Yersinia ruckeri/efectos de los fármacos , Yersinia ruckeri/genética , Animales , Proteínas Bacterianas/genética , Enfermedades de los Peces/microbiología , Prueba de Complementación Genética , Aptitud Genética , Pruebas de Sensibilidad Microbiana , Oncorhynchus mykiss/microbiología , Porinas/genética , Selección Genética , Yersiniosis/microbiología , Yersiniosis/veterinaria , Yersinia ruckeri/patogenicidadRESUMEN
Tightened regulations and an environmentally friendly approaches in fish production have greatly reduced the use of antibiotics but green solutions are continuously being explored. The use of functional feed may have a potential in the aquaculture sector in securing biomass and minimizing the loss from disease. In the present study, we tested the concept that blood from the fish slaughterhouse can be used for mass purification of specific antibodies which subsequently can be used for feeding fish and thereby confer protection against diseases. IgM was purified from serum from Yersinia ruckeri vaccinated rainbow trout and an IgM sandwich ELISA was developed for quantification of rainbow trout IgM. The purified IgM was encapsulated in alginate microparticles and top-coated in fish feed. IgM re-extracted from the alginate microparticles was shown to retain high reactivity towards Y. ruckeri antigens indicating that its bioactivity remained intact after encapsulation. IgM release from the alginate microparticles was only observed at high pH (pH 8.2) and minimal at low pH, indicating protection of IgM at low pH in the fish stomach during passage. In a feeding - challenge experiment (feeding 1 week before Y. ruckeri challenge and for two weeks following challenge), a statistically non-significant 10% lower mortality was observed in the high dose (400⯵g IgM/fish/day fed over 3 weeks) group.
Asunto(s)
Enfermedades de los Peces/inmunología , Inmunoglobulina M/metabolismo , Oncorhynchus mykiss/inmunología , Sustancias Protectoras/metabolismo , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Enfermedades de los Peces/tratamiento farmacológico , Inmunoglobulina M/administración & dosificación , Sustancias Protectoras/administración & dosificación , Yersiniosis/tratamiento farmacológico , Yersiniosis/inmunologíaRESUMEN
In this study, we evaluated the impact of the catecholamines on growth, swimming motility, biofilm formation and some virulence factors activities of pathogenic Yersinia ruckeri. Norepinephrine and dopamine (at 100 µM) significantly increased the growth of Y. ruckeri in culture media containing serum. An increase in swimming motility of the pathogen was found following the exposure to the hormones; however, no effect was seen on caseinase, phospholipase and haemolysin productions. Further, antagonists for the catecholamine receptors were observed to block some of the influences of the catecholamines. Indeed, the effects of catecholamines were inhibited by chlorpromazine (the dopaminergic receptor antagonist) for dopamine, labetalol (α-and ß-adrenergic receptor antagonist) and phenoxybenzamine (the α-adrenergic receptor antagonist) for norepinephrine, but propranolol (the ß-adrenergic receptor antagonist) showed no effect. Pretreatment of Y. ruckeri with the catecholamines resulted in a significant enhancement of its virulence towards rainbow trout and the antagonists could neutralize the effect of the stress hormones in vivo. In summary, our results show that the catecholamines increase the virulence of Y. ruckeri which is pathogenic to trout through increasing the motility, biofilm formation and growth.
Asunto(s)
Biopelículas/efectos de los fármacos , Catecolaminas/farmacología , Oncorhynchus mykiss/microbiología , Yersinia ruckeri/efectos de los fármacos , Animales , Dopamina/farmacología , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/prevención & control , Locomoción/efectos de los fármacos , Norepinefrina/farmacología , Virulencia , Factores de Virulencia/metabolismo , Yersinia ruckeri/fisiologíaRESUMEN
Five N-acyl homoserine lactone-degrading bacteria (quorum quenching (QQ) strains) were selected to evaluate their impacts on growth, virulence factors and biofilm formation in Yersinia ruckeri in vitro. No difference was observed among the growth pattern of Y. ruckeri in monoculture and coculture with the QQ strains. To investigate the regulation of virulence factors by quorum sensing in Y. ruckeri, cultures were supplemented with 3oxo-C8-HSL. The results indicated that swimming motility and biofilm formation are positively regulated by QS (p < 0.05), whereas caseinase, phospholipase and haemolysin productions are not influenced by 3oxo-C8-HSL (p > 0.05). The QQs were able to decrease swimming motility and biofilm formation in Y. ruckeri. QQ bacteria were supplemented to trout feed at 108 CFU/g (for 40 days). Their probiotic effect was verified by Y. ruckeri challenge either by immersion or injection in trout. All strains could significantly increase fish survival with Bacillus thuringiensis and Citrobacter gillenii showing the highest and lowest relative percentage survival (RPS) values (respectively, 85% and 38%). Besides, there was no difference between the RPS values by either immersion or injection challenge expect for B. thuringiensis. The putative involvement of the QQ capacity in the protection against Yersinia is discussed.
Asunto(s)
Oncorhynchus mykiss/microbiología , Probióticos/administración & dosificación , Probióticos/farmacología , Percepción de Quorum , Yersinia ruckeri/crecimiento & desarrollo , Yersinia ruckeri/patogenicidad , 4-Butirolactona/análogos & derivados , 4-Butirolactona/química , 4-Butirolactona/metabolismo , 4-Butirolactona/farmacología , Animales , Bacillus thuringiensis/fisiología , Biopelículas/efectos de los fármacos , Citrobacter/fisiología , Medios de Cultivo/química , Medios de Cultivo/farmacología , Enfermedades de los Peces/microbiología , Alimentos , Probióticos/uso terapéutico , Factores de Virulencia , Yersiniosis/microbiología , Yersinia ruckeri/efectos de los fármacos , Yersinia ruckeri/fisiologíaRESUMEN
Due to the rapid emergence of resistance to classical antibiotics, novel antimicrobial compounds are needed. It is desirable to selectively kill pathogenic bacteria without targeting other beneficial bacteria in order to prevent the negative clinical consequences caused by many broad-spectrum antibiotics as well as reducing the development of antibiotic resistance. Antimicrobial peptides (AMPs) represent an alternative to classical antibiotics and it has been previously demonstrated that Cap18 has high antimicrobial activity against a broad range of bacterial species. In this study we report the design of a positional scanning library consisting of 696 Cap18 derivatives and the subsequent screening for antimicrobial activity against Y. ruckeri, A. salmonicida, S. Typhimurium and L. lactis as well as for hemolytic activity measuring the hemoglobin release of horse erythrocytes. We show that the hydrophobic face of Cap18, in particular I13, L17 and I24, is essential for its antimicrobial activity against S. Typhimurium, Y. ruckeri, A. salmonicida, E. coli, P. aeruginosa, L. lactis, L. monocytogenes and E. faecalis. In particular, Cap18 derivatives harboring a I13D, L17D, L17P, I24D or I24N substitution lost their antimicrobial activity against any of the tested bacterial strains. In addition, we were able to generate species-specific Cap18 derivatives by particular amino acid substitutions either in the hydrophobic face at positions L6, L17, I20, and I27, or in the hydrophilic face at positions K16 and K18. Finally, our data showed the proline residue at position 29 to be essential for the inherent low hemolytic activity of Cap18 and that substitution of the residues K16, K23, or G21 by any hydrophobic residues enhances the hemolytic activity. This study demonstrates the potential of generating species-specific AMPs for the selective elimination of bacterial pathogens.
Asunto(s)
Antiinfecciosos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Hemolíticos/farmacología , Aeromonas salmonicida/efectos de los fármacos , Sustitución de Aminoácidos , Animales , Antiinfecciosos/química , Péptidos Catiónicos Antimicrobianos/química , Péptidos Catiónicos Antimicrobianos/genética , Diseño de Fármacos , Eritrocitos/efectos de los fármacos , Hemolíticos/química , Caballos , Pruebas de Sensibilidad Microbiana , Biblioteca de Péptidos , Salmonella typhimurium/efectos de los fármacos , Yersinia ruckeri/efectos de los fármacos , CatelicidinasAsunto(s)
Vacunas Bacterianas/administración & dosificación , Enfermedades de los Peces/prevención & control , Viabilidad Microbiana , Salmo salar/microbiología , Vacunación/veterinaria , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Pruebas de Aglutinación , Sulfato de Amonio/farmacología , Animales , Anticuerpos Antibacterianos/sangre , Enfermedades de los Peces/microbiología , Formaldehído/farmacología , Calor , Vacunación/métodos , Yersiniosis/prevención & controlRESUMEN
Yersinia ruckeri is the causative agent of enteric redmouth disease (ERM) of salmonids. There is little information regarding the proteomics of Y. ruckeri. Herein, we perform whole protein identification and quantification of biotype 1 and biotype 2 strains of Y. ruckeri grown under standard culture conditions using a shotgun proteomic approach. Proteins were extracted, digested and peptides were separated by a nano liquid chromatography system and analyzed with a high-resolution hybrid triple quadrupole time of flight mass spectrometer coupled via a nano ESI interface. SWATH-MS technology and sophisticated statistical analyses were used to identify proteome differences among virulent and avirulent strains. GO annotation, subcellular localization, virulence proteins and antibiotic resistance ontology were predicted using bioinformatic tools. A total of 1395 proteins were identified in the whole cell of Y. ruckeri. These included proteases, chaperones, cell division proteins, outer membrane proteins, lipoproteins, receptors, ion binding proteins, transporters and catalytic proteins. In virulent strains, a total of 16 proteins were upregulated including anti-sigma regulatory factor, arginine deiminase, phosphate-binding protein PstS and superoxide dismutase Cu-Zu. Additionally, several virulence proteins were predicted such as Clp and Lon pro-teases, TolB, PPIases, PstS, PhoP and LuxR family transcriptional regulators. These putative virulence proteins might be used for development of novel targets for treatment of ERM in fish. Our study represents one of the first global proteomic reference profiles of Y. ruckeri and this data can be accessed via ProteomeXchange with identifier PXD005439. These proteomic profiles elucidate proteomic mechanisms, pathogenicity, host-interactions, antibiotic resistance ontology and localization of Y. ruckeri proteins.
Asunto(s)
Yersinia ruckeri/genética , Animales , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/aislamiento & purificación , Farmacorresistencia Bacteriana/genética , Enfermedades de los Peces/microbiología , Ontología de Genes , Proteómica/métodos , Yersiniosis/microbiología , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacosRESUMEN
In this study, we compared 142 Yersinia ruckeri isolates collected between 2013 and 2016 from 6 different regions in Turkey. A total of 18 different genogroups were found, though most of the isolates clustered into the same genogroup as serotype O1. As immunization of fish with inactivated Y. ruckeri by injection, immersion, or feeding provide minimal protection against Y. ruckeri infection in Turkey, many fish producers use antimicrobials unrestrictedly, resulting in antimicrobial resistance in aquatic pathogens. Accordingly, we investigated resistance to the antimicrobials most commonly used to treat yersiniosis. More than 80% of the Y. ruckeri isolates were susceptible to sulfamethoxazole-trimethoprim (SXT), florfenicol (FFC), and tetracycline, whereas none were susceptible to sulfamethoxazole. The most commonly used antimicrobials (SXT and FFC) can be effectively administered because the resistance levels to these drugs are the lowest among those reported for agents used to control enteric red mouth disease (12.6 and 14.7%, respectively). In conclusion, to the best of our knowledge, this study is the first characterization of the antimicrobial resistance genes floR, sulI, tetC, tetD, and tetE in Y. ruckeri isolates from aquaculture. Additionally, we detected the sulII gene but not the tetA, tetB, tetM, tetS, or sulIII genes.
Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Enfermedades de los Peces/microbiología , Genotipo , Yersiniosis/veterinaria , Yersinia ruckeri/genética , Animales , Enfermedades de los Peces/epidemiología , Pruebas de Sensibilidad Microbiana , Oncorhynchus mykiss , Variantes Farmacogenómicas , Turquía/epidemiología , Yersiniosis/epidemiología , Yersiniosis/microbiología , Yersinia ruckeri/efectos de los fármacosRESUMEN
The antimicrobial peptide CAP18 has been demonstrated to have a strong in vitro bactericidal effect on Yersinia ruckeri, but its activity in vivo has not been described. In this work, we investigated whether CAP18 protects rainbow trout Oncorhynchus mykiss (Walbaum) against enteric red mouth disease caused by this pathogen either following i.p. injection or by oral administration (in feed). It was found that injection of CAP18 into juvenile rainbow trout before exposure to Y. ruckeri was associated with lowered mortality compared to non-medicated fish although it was less effective than the conventional antibiotic oxolinic acid. Oral administration of CAP18 to trout did not prevent infection. The proteolytic effect of secretions on the peptide CAP18 in the fish gastrointestinal tract is suggested to account for the inferior effect of oral administration.
Asunto(s)
Antiinfecciosos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Enfermedades de los Peces/prevención & control , Oncorhynchus mykiss , Vacunación/veterinaria , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Administración Oral , Animales , Antiinfecciosos/administración & dosificación , Péptidos Catiónicos Antimicrobianos/administración & dosificación , Enfermedades de los Peces/microbiología , Inyecciones Intraperitoneales/veterinaria , Yersiniosis/microbiología , Yersiniosis/prevención & control , CatelicidinasRESUMEN
Peracetic acid (PAA) is a therapeutic agent used for disinfection in aquaculture, but it must be investigated thoroughly in order to mitigate diseases without harming the fish. Successful disinfectants (like PAA) should not leave dangerous residues in the environment in order to successfully contribute to sustainable aquaculture. The aim of our study was to compare the effectiveness of 6 commercial PAA products with different molecular PAA:H2O2 ratios to reduce bacterial growth of Aeromonas salmonicida and Yersinia ruckeri and to determine effective concentrations and exposure times. All products reduced colony-forming units (CFUs) of A. salmonicida and Y. ruckeri. Products with higher molecular PAA:H2O2 ratios inhibited growth better than products with lower molecular PAA:H2O2 ratios at the same PAA concentration; this indicates that H2O2 is not the driving force in the reduction of A. salmonicida and Y. ruckeri growth by PAA in vitro. The practical application of the products with high molecular PAA:H2O2 ratios should be prioritized if these pathogens are diagnosed.
Asunto(s)
Aeromonas salmonicida/efectos de los fármacos , Desinfectantes/farmacología , Ácido Peracético/farmacología , Yersinia ruckeri/efectos de los fármacos , Desinfectantes/química , Ácido Peracético/químicaRESUMEN
Background Enteric red mouth disease and Saprolegniasis, which are caused by the bacteria Yersinia ruckeri and the oomycete Saprolegnia parasitica, respectively, are important illnesses that affect salmonid farming. Sanitary problems in farms are addressed by the prevention of disease outbreaks or by the treatment of diseases with chemicals. Environmental and governmental restrictions, toxicity and high treatment costs limit the use of drugs. Marine organisms, such as algae, sponges and corals, have developed an antimicrobial defense strategy based on the production of bioactive metabolites. Among these organisms, seaweeds offer a particularly rich source of potential new drugs. Hence, many pharmacologically active substances have been isolated from seaweeds. In the Ceramium genus, Ceramium rubrum has been emphasized by several authors for its antimicrobial properties. Based on this background, the present study focused on the antimicrobial activity of a lipophilic extract of C. rubrum on Y. ruckeri and S. parasitica. Results The alga, collected from the Pacific coast of Chile, underwent an ethanol extraction, and the concentrated extract was partitioned between water and dichloromethane. From the dichloromethane extract, fatty acids, fatty acid esters, one hydrocarbon and phytol were identified by Gas Chromatography-Mass Spectrometry (GC/MS) analysis. The antimicrobial study showed that the whole extract was more active than the individual components, which suggests a strong synergistic effect among the components. Conclusions These results may constitute a basis for promising future applied research that could investigate the use of C. rubrum seaweed as a source of antimicrobial compounds against fish pathogens.
Asunto(s)
Animales , Extractos Vegetales/farmacología , Saprolegnia/efectos de los fármacos , Yersinia ruckeri/efectos de los fármacos , Rhodophyta/química , Enfermedades de los Peces , Cloruro de Metileno/farmacología , Antiinfecciosos/farmacología , Salmonidae , Algas Marinas , Recuento de Colonia Microbiana , Cromatografía de Gases y Espectrometría de MasasRESUMEN
The effect of oral vaccines against bacterial fish diseases has been a topic for debate for decades. Recently both M-like cells and dendritic cells have been discovered in the intestine of rainbow trout. It is therefore likely that antigens reaching the intestine can be taken up and thereby induce immunity in orally vaccinated fish. The objective of this project was to investigate whether oral and anal vaccination of rainbow trout induces protection against an experimental waterborne infection with the pathogenic enterobacteria Yersinia ruckeri O1 biotype 1 the causative agent of enteric redmouth disease (ERM). Rainbow trout were orally vaccinated with AquaVac ERM Oral (MERCK Animal Health) or an experimental vaccine bacterin of Y. ruckeri O1. Both vaccines were tested with and without a booster vaccination four months post the primary vaccination. Furthermore, two groups of positive controls were included, one group receiving the experimental oral vaccine in a 50 times higher dose, and the other group receiving a single dose administered anally in order to bypass the stomach. Each group was bath challenged with 6.3 × 10(8) CFU/ml Y. ruckeri, six months post the primary vaccination. The challenge induced significant mortality in all the infected groups except for the groups vaccinated anally with a single dose or orally with the high dose of bacterin. Both of these groups had 100% survival. These results show that a low dose of Y. ruckeri bacterin induces full protection when the bacterin is administered anally. Oral vaccination also induces full protection, however, at a dose 50 times higher than if the fish were to be vaccinated anally. This indicates that much of the orally fed antigen is digested in the stomach before it reaches the second segment of the intestine where it can be taken up as immunogenic antigens and presented to lymphocytes.
Asunto(s)
Vacunas Bacterianas/farmacología , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/prevención & control , Oncorhynchus mykiss , Vacunación/veterinaria , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Administración Oral , Administración Rectal , Animales , Vacunas Bacterianas/administración & dosificación , Ensayo de Inmunoadsorción Enzimática/veterinaria , Riñón Cefálico/microbiología , Inmunohistoquímica/veterinaria , Resultado del Tratamiento , Yersiniosis/prevención & controlRESUMEN
The antibacterial properties of water-soluble gold(I) complexes [1-methyl-3-(3-sulfonatopropyl)imidazol-2-ylidene]gold(I) chloride (C1), [1-mesityl-3-(3-sulfonatopropyl)imidazol-2-ylidene]gold(I) chloride (C2), [1-(2,6-diisopropylphenyl)-3-(3-sulfonatopropyl)imidazol-2-ylidene]gold(I) chloride (C3) and [1,3-bis(2,6-diisopropyl-4-sodiumsulfonatophenyl)imidazol-2-ylidene]gold(I) chloride (C4) and the respective ligands were assessed by agar diffusion and broth macrodilution methods against Gram-positives Staphylococcus aureus, Enterococcus faecalis and Micrococcus luteus and the Gram-negative bacteria Yersinia ruckeri, Pseudomonas aeruginosa and Escherichia coli. Viability after treatments was determined by direct plate count. The bactericidal activity displayed by C1 and C3 was comparable to that of AgNO3.